21
Participants
Start Date
June 12, 2019
Primary Completion Date
March 18, 2021
Study Completion Date
September 29, 2022
HX009
During study treatment, subjects will receive HX009 treatment via IV infusion once every 2 weeks at doses of 0.1, 0.3, 1, 2, 3, 5, and 7.5 mg/kg.
St George Private Hospital, Kogarah
Waterstone Hanxbio Pty Ltd
INDUSTRY